The company will shell out $2.2 billion over allegations of marketing misconduct for Risperdal, Invega and Natrecor.
Quintiles buys a CRO; Forest and Almirall delay their COPD combo drug; and Paula Deen may pop up on the Food Network Sunday
Medscape asked and doctors shared what they hate about most medical apps, Livestrong merch hits the clearance rack, healthcare reform savings begin to surface, Lilly releases early RA drug trial results
Lance Armstrong's story is about more than cycling. PR and brand experts weighed in on how they would safeguard his cancer foundation's reputation.
Viagra and Cialis took top honors for most trusted pharmaceutical brands in a poll of physicians.
The Women's Health landscape is ripe with opportunity for pharma marketers. This seven-page eBook offers product managers a guide to capitalizing on the trends, growth areas and unmet needs. Includes alternative channels to engage OB/GYNs and oncologists, and plenty of tips. Click here to access it.